SMC, a global contract manufacturer of pharmaceutical and finished medical devices, announced that it has acquired Oval Medical Technologies, a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, U.K.
Oval’s autoinjector platforms address the unmet needs in the self-injection market utilizing both cyclic olefin plastic and glass primary drug containers. Their autoinjectors deliver both non-viscous and viscous drugs. The convenient design of the autoinjector provides patients with an ease-of-use solution for fast and simple two-step administration in emergency and non-emergency environments. This unique platform is available to pharmaceutical companies for their drug delivery systems.
SMC’s global healthcare contract manufacturing expertise enables SMC and Oval to become a comprehensive combination product solution provider for the pharmaceutical industry.
“We are excited to have Oval Medical Technologies within the SMC family. SMC’s years of experience in medical device contract manufacturing paired with Oval’s innovative approach to drug delivery combination products creates a complete solution for the pharmaceutical market. In addition to autoinjectors, the Oval team brings a wealth of knowledge and experience in the design, development and manufacturing of inhalation products,” said Chetan N. Patel, president and founder of SMC.
“Pharmaceutical companies require reliable customized devices for their high-value biologics. As part of SMC, Oval will be well placed to provide customers with devices that meet their needs and those of their patients. The combination of Oval’s design and development capability and SMC’s capabilities in global manufacturing will ensure a high level of reliability in product performance and a fast route to market. These capabilities are also important for the acceleration of the development of our innovative Epinephrine combination product. This small innovative, and reliable design is favored by patients who need to carry these potentially lifesaving products at all times,” said Barbara Lead, CEO of Oval Medical Technologies.